secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2024-06-28T23:59:59+00:00
Accession:  0001104659-24-076313
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth amends Series B and B-1 Preferred Stock, extends conversion period, adds dividends
--------------------------------------------------------------------------------

- Mandatory conversion period extended from 15 to 18 months from original issue date.
- Series B and B-1 holders get 10% dividend for fifth full quarter, 25% for sixth quarter from closing.
- No additional securities were issued or sold as a result of the amendment.
- Amendments filed on June 25, 2024, effective upon filing with Delaware Secretary of State.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465924076313/0001104659-24-076313-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465924076313/tm2418444d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-076313

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer